Gilteritinib

Also known as Xospata (us)

Save $6,009/mo

3× cheaper

Gilteritinib is used to treat a certain type of acute myeloid leukemia (AML) that has worsened or returned after treatment with other chemotherapy medications.

United States

$9,114

per month

India

$3,105

per month

You save

$6,009

66% cheaper in India

4.8K US scripts/yr$28.9M potential annual savings$43.8M US spend/yr

Building 3D structure…

Drag to rotate · 3D structureC₂₉H₄₄N₈O₃

SMILES: CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5

Compare the price

US price$9,114per month

India price$3,105per month

You save$6,00966% less

Based on 30 units per month. US $303.80 vs India $103.50 per unit.

How many months / courses?

Total over 1 periodSave $6,009$9,114 → $3,105

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $36,053
Estimated travel cost: − $2,300
Net savings after travel: $33,753

Even after travel, you could come out ahead by about $33,753.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Gilteritinib is filled about 4.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$43.8M

If sourced from India

$14.9M

Potential annual savings

$28.9M

−66%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.